These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 2869762

  • 1. Relative bioavailability in humans for oral tablets and solutions of lormetazepam.
    Zecca L, Reina L, Scaglione F, Ferrario P, Pirola R, Ceccarelli G, Ciampini M, Fraschini F.
    Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762
    [Abstract] [Full Text] [Related]

  • 2. Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing.
    Luscombe DK.
    Psychopharmacology Suppl; 1984; 1():99-104. PubMed ID: 6147846
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic correlates of modified absorption: studies with lormetazepam.
    Pierce DM, Franklin RA, Harry TV, Nicholson AN.
    Br J Clin Pharmacol; 1984 Jul; 18(1):31-5. PubMed ID: 6146348
    [Abstract] [Full Text] [Related]

  • 4. [Screening, detection and biotransformation of lormetazepam, a new hypnotic agent from the 1,4-benzodiazepine series (author's transl)].
    Schütz H, Fitz H.
    Arzneimittelforschung; 1982 Jul; 32(3):177-83. PubMed ID: 6123328
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam.
    Kurowski M, Ott H, Herrmann WM.
    Pharmacopsychiatria; 1982 May; 15(3):77-83. PubMed ID: 6124982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical pharmacokinetics of lorazepam: a review.
    Kyriakopoulos AA, Greenblatt DJ, Shader RI.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A new lormetazepam galenical formulation for sublingual premedication.
    Van Boven MJ, Scholtes JL, Collard E, Van Obbergh L, Gribomont BF.
    Acta Anaesthesiol Belg; 1988 Oct; 39(4):233-7. PubMed ID: 2906778
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bioavailability of three oral dosage forms of cisapride, a gastrointestinal stimulant agent.
    Barone JA, Huang YC, Bierman RH, Colaizzi JL, Long JF, Kerr DA, Van Peer A, Woestenborghs R, Heykants J.
    Clin Pharm; 1987 Aug; 6(8):640-5. PubMed ID: 3691010
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
    Rey E, d'Athis P, Richard MO, de Lauture D, Olive G.
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.